[{"id":"e3f5ed5f-4b5f-4871-aebb-6134c691951a","acronym":"","url":"https://clinicaltrials.gov/study/NCT02799680","created_at":"2021-01-18T13:44:06.964Z","updated_at":"2024-07-02T16:37:31.316Z","phase":"Phase 1","brief_title":"Allogeneic CART-33 for Relapsed/Refractory CD33+ AML","source_id_and_acronym":"NCT02799680","lead_sponsor":"The Affiliated Hospital of the Chinese Academy of Military Medical Sciences","biomarkers":" CD33","pipe":" | ","alterations":" CD33 positive","tags":["CD33"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD33 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CART-33"],"overall_status":"Unknown status","enrollment":" Enrollment 12","initiation":"Initiation: 10/01/2015","start_date":" 10/01/2015","primary_txt":" Primary completion: 05/01/2017","primary_completion_date":" 05/01/2017","study_txt":" Completion: 05/01/2018","study_completion_date":" 05/01/2018","last_update_posted":"2016-06-15"}]